Display options
Share it on
Full text links
Silverchair Information Systems

J Clin Endocrinol Metab. 1985 Aug;61(2):285-90. doi: 10.1210/jcem-61-2-285.

Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II.

The Journal of clinical endocrinology and metabolism

D S Rao, A M Parfitt, M Kleerekoper, B S Pumo, B Frame

PMID: 2989317 DOI: 10.1210/jcem-61-2-285

Abstract

In 6 of 8 adults with severe hypocalcemia and osteomalacia due to vitamin D depletion, basal excretion of nephrogenous cAMP (NcAMP) was increased, but the mean renal phosphate threshold (TmP/GFR) was normal, indicating that the steady state phosphaturic response to cAMP generated by endogenous PTH was impaired, as in pseudohypoparathyroidism type II. In all 6 patients, correction of hypocalcemia by administration of vitamin D and calcium restored the normal relationship between NcAMP and TmP/GFR. By contrast, in 13 patients with normocalcemic osteomalacia due to vitamin D depletion, TmP/GFR was reduced, with a significant negative regression on NcAMP, and rose to normal after treatment. Bone histomorphometry after double tetracycline labeling did not differ significantly between the 2 groups. In 72 patients with primary hyperparathyroidism, the slope of the negative regression of TmP/GFR on NcAMP was the same as in normocalcemic secondary hyperparathyroidism, but the adjusted mean for TmP/GFR was significantly lower. We conclude that the effect of endogenous PTH on phosphate reabsorption varies with the level of plasma calcium, and that dissociation between this effect and the generation of cAMP is nonspecific and can be a consequence of hypocalcemia. Exclusion of vitamin D depletion should be an additional diagnostic criterion for pseudohypoparathyroidism type II.

Similar articles

Show all 11 similar articles

Cited by

Seymen-Karabulut G, Günlemez A, Gökalp AS, Hatun Ş, Kaya Narter F, Mutlu M, Kader Ş, Terek D, Hanta D, Okulu E, Karadeniz L, Kanmaz Kutman HG, Zenciroğlu A, Özdemir ÖMA, Sarıcı D, Çelik M, Demir N, Turan Ö, Çelik K, Kılıçbay F, Uslu S, Erol S, Ertuğrul S, Er İ, Çelik HT, Çetinkaya M, Aktürk-Acar F, Aslan Y, Tunç G, Güran Ö, Engin Arısoy A.
J Clin Res Pediatr Endocrinol. 2021 Nov 25;13(4):384-390. doi: 10.4274/jcrpe.galenos.2020.2021.0169. Epub 2021 May 20.
PMID: 34013710

Seymen-Karabulut G, Günlemez A, Gökalp AS, Hatun Ş, Kaya Narter F, Mutlu M, Kader Ş, Terek D, Hanta D, Okulu E, Karadeniz L, Kanmaz Kutman HG, Zenciroğlu A, Özdemir ÖMA, Sarıcı D, Çelik M, Demir N, Turan Ö, Çelik K, Kılıçbay F, Uslu S, Erol S, Ertuğrul S, Er İ, Çelik HT, Çetinkaya M, Aktürk-Acar F, Aslan Y, Tunç G, Güran Ö, Engin Arısoy A.
J Clin Res Pediatr Endocrinol. 2021 Nov 25;13(4):384-390. doi: 10.4274/jcrpe.galenos.2020.2021.0169. Epub 2021 May 20.
PMID: 34013710

Substances

MeSH terms

Publication Types

LinkOut - more resources